找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Incentives for Research, Development, and Innovation in Pharmaceuticals; Walter García-Fontes Textbook 2011 Springer Healthcare Iberica, S

[复制链接]
查看: 46912|回复: 37
发表于 2025-3-21 17:07:18 | 显示全部楼层 |阅读模式
书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals
编辑Walter García-Fontes
视频videohttp://file.papertrans.cn/464/463216/463216.mp4
概述In-depth discussion of neglected health economics issues.Includes up to date analysis of new data.Written by a collection of the leading minds in the field.Ground breaking ideas to enhance research an
丛书名称Series economia de la salud y gestion sanitaria
图书封面Titlebook: Incentives for Research, Development, and Innovation in Pharmaceuticals;  Walter García-Fontes Textbook 2011 Springer Healthcare Iberica, S
描述Incentives for innovation are particularly relevant in the pharmaceutical industry where not all social needs provide equally profitable opportunities and where most OECD countries try to implement different measures that promote research in these less profitable areas. This book describes how incentives can be provided to deal with less profitable activities when no clear markets exist for the innovations. The book discusses alternative mechanisms to substitute for inexistent markets, situations where traditional instruments have proven totally insufficient, and the clear mismatch between the size of the markets being targeted and the incentives being provided. Patents become an ineffective way to incentivise R&D when the appropriability is low; this book provides alternative ideas such as allowing for a period of data exclusivity to firms that develop new drugs.
出版日期Textbook 2011
关键词Drug develoment; Innovation; Pharmaceutical industry; Research and Development; patent law
版次1
doihttps://doi.org/10.1007/978-84-938062-7-9
isbn_softcover978-84-938062-1-7
isbn_ebook978-84-938062-7-9
copyrightSpringer Healthcare Iberica, S.L. 2011
The information of publication is updating

书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals影响因子(影响力)




书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals影响因子(影响力)学科排名




书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals网络公开度




书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals网络公开度学科排名




书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals被引频次




书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals被引频次学科排名




书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals年度引用




书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals年度引用学科排名




书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals读者反馈




书目名称Incentives for Research, Development, and Innovation in Pharmaceuticals读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:34:52 | 显示全部楼层
,The Contribution of the United States, Europe and Japan in Discovering New Drugs: 1982–2003,ber of global, first-in-class, biotech and orphan drugs exhibited more positive trends. U.S. headquartered firms also assumed a strong leadership position in terms of being the initial introducers of the most novel compounds including first-in-class, biotech and orphan drugs.
发表于 2025-3-22 01:58:57 | 显示全部楼层
When patents are not enough: Supplementary incentives for pharmaceutical innovation, where for some reason the value of the patent reward is relatively low compared to the social value created by the innovation: that is, where the . of social value is low. In these cases, firms will fail to invest in innovation even though its value to society is high.
发表于 2025-3-22 08:10:41 | 显示全部楼层
发表于 2025-3-22 12:26:05 | 显示全部楼层
发表于 2025-3-22 14:17:59 | 显示全部楼层
发表于 2025-3-22 17:48:48 | 显示全部楼层
发表于 2025-3-22 23:03:28 | 显示全部楼层
Textbook 2011 size of the markets being targeted and the incentives being provided. Patents become an ineffective way to incentivise R&D when the appropriability is low; this book provides alternative ideas such as allowing for a period of data exclusivity to firms that develop new drugs.
发表于 2025-3-23 01:43:44 | 显示全部楼层
发表于 2025-3-23 06:49:20 | 显示全部楼层
Aidan Hollisut program into a sequence of steps in a machine program, and they then describe the interfaces between the modules. Finally, the structures of real translators are outlined. The book contains the necessary theory and advice for implementation.. .This book is intended for students of computer scienc
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-5 06:22
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表